IL 3625 (Theophylline extended-release 300 mg)
Pill imprint IL 3625 has been identified as Theophylline extended-release 300 mg.
Theophylline is used in the treatment of asthma, maintenance; asthma, acute; apnea of prematurity and belongs to the drug class methylxanthines. Risk cannot be ruled out during pregnancy. Theophylline 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for IL 3625 (Theophylline extended-release 300 mg)
Theophylline extended-release
- Imprint:
-
IL
3625 - Strength:
- 300 mg
- Color:
- White / Clear
- Size:
- 17.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Methylxanthines
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Inwood Laboratories Inc.
- National Drug Code (NDC):
- 00258-3625
- Inactive Ingredients:
- ferric oxide black
butylparaben
castor oil
edetate calcium disodium
ethylcellulose
gelatin
methylparaben
pharmaceutical glaze
povidone
propylparaben
sodium lauryl sulfate
sodium propionate
starch
sugar spheres
magnesium silicate
titanium dioxide
More resources
Theophylline extended-release is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
